These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Computational approaches for the design of modulators targeting protein-protein interactions. Rehman AU; Khurshid B; Ali Y; Rasheed S; Wadood A; Ng HL; Chen HF; Wei Z; Luo R; Zhang J Expert Opin Drug Discov; 2023 Mar; 18(3):315-333. PubMed ID: 36715303 [TBL] [Abstract][Full Text] [Related]
7. Rational modulator design by exploitation of protein-protein complex structures. Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413 [TBL] [Abstract][Full Text] [Related]
8. Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools. Vincenzi M; Mercurio FA; Leone M Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339078 [TBL] [Abstract][Full Text] [Related]
10. Stabilized cyclic peptides as modulators of protein-protein interactions: promising strategies and biological evaluation. Cheng J; Zhou J; Kong L; Wang H; Zhang Y; Wang X; Liu G; Chu Q RSC Med Chem; 2023 Dec; 14(12):2496-2508. PubMed ID: 38107173 [TBL] [Abstract][Full Text] [Related]
11. Assessing the performance of MM/PBSA and MM/GBSA methods. 9. Prediction reliability of binding affinities and binding poses for protein-peptide complexes. Weng G; Wang E; Chen F; Sun H; Wang Z; Hou T Phys Chem Chem Phys; 2019 May; 21(19):10135-10145. PubMed ID: 31062799 [TBL] [Abstract][Full Text] [Related]
12. Improved prediction of protein-protein interactions by a modified strategy using three conventional docking software in combination. Choi S; Son SH; Kim MY; Na I; Uversky VN; Kim CG Int J Biol Macromol; 2023 Dec; 252():126526. PubMed ID: 37633550 [TBL] [Abstract][Full Text] [Related]
13. Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery. Trisciuzzi D; Villoutreix BO; Siragusa L; Baroni M; Cruciani G; Nicolotti O Expert Opin Drug Discov; 2023 Jul; 18(7):737-752. PubMed ID: 37246811 [TBL] [Abstract][Full Text] [Related]
14. Cyclic and Macrocyclic Peptides as Chemical Tools To Recognise Protein Surfaces and Probe Protein-Protein Interactions. Cardote TA; Ciulli A ChemMedChem; 2016 Apr; 11(8):787-94. PubMed ID: 26563831 [TBL] [Abstract][Full Text] [Related]
15. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data. Sugaya N; Ikeda K; Tashiro T; Takeda S; Otomo J; Ishida Y; Shiratori A; Toyoda A; Noguchi H; Takeda T; Kuhara S; Sakaki Y; Iwayanagi T BMC Pharmacol; 2007 Aug; 7():10. PubMed ID: 17705877 [TBL] [Abstract][Full Text] [Related]
16. State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors. Sheng C; Dong G; Miao Z; Zhang W; Wang W Chem Soc Rev; 2015 Nov; 44(22):8238-59. PubMed ID: 26248294 [TBL] [Abstract][Full Text] [Related]
17. Computational approaches to developing short cyclic peptide modulators of protein-protein interactions. Duffy FJ; Devocelle M; Shields DC Methods Mol Biol; 2015; 1268():241-71. PubMed ID: 25555728 [TBL] [Abstract][Full Text] [Related]
18. Modeling the MreB-CbtA Interaction to Facilitate the Prediction and Design of Candidate Antibacterial Peptides. Awuni E Front Mol Biosci; 2021; 8():814935. PubMed ID: 35155572 [TBL] [Abstract][Full Text] [Related]
19. Applications of in Silico Methods for Design and Development of Drugs Targeting Protein-Protein Interactions. Cicaloni V; Trezza A; Pettini F; Spiga O Curr Top Med Chem; 2019; 19(7):534-554. PubMed ID: 30836920 [TBL] [Abstract][Full Text] [Related]
20. In silico structure-based approaches to discover protein-protein interaction-targeting drugs. Shin WH; Christoffer CW; Kihara D Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]